GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cogentix Medical Inc (NAS:CGNT) » Definitions » Interest Coverage

Cogentix Medical (Cogentix Medical) Interest Coverage : 4.86 (As of Dec. 2017)


View and export this data going back to 1992. Start your Free Trial

What is Cogentix Medical Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Cogentix Medical's Operating Income for the three months ended in Dec. 2017 was $0.14 Mil. Cogentix Medical's Interest Expense for the three months ended in Dec. 2017 was $-0.03 Mil. Cogentix Medical's interest coverage for the quarter that ended in Dec. 2017 was 4.86. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Cogentix Medical's Interest Coverage or its related term are showing as below:


CGNT's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 19.41
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Cogentix Medical Interest Coverage Historical Data

The historical data trend for Cogentix Medical's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cogentix Medical Interest Coverage Chart

Cogentix Medical Annual Data
Trend Mar08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Dec16 Dec17
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - N/A 0.34 -

Cogentix Medical Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.15 No Debt No Debt N/A 4.86

Competitive Comparison of Cogentix Medical's Interest Coverage

For the Medical Devices subindustry, Cogentix Medical's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cogentix Medical's Interest Coverage Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cogentix Medical's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Cogentix Medical's Interest Coverage falls into.



Cogentix Medical Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cogentix Medical's Interest Coverage for the fiscal year that ended in Dec. 2017 is calculated as

Here, for the fiscal year that ended in Dec. 2017, Cogentix Medical's Interest Expense was $-0.03 Mil. Its Operating Income was $-0.89 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Cogentix Medical did not have earnings to cover the interest expense.

Cogentix Medical's Interest Coverage for the quarter that ended in Dec. 2017 is calculated as

Here, for the three months ended in Dec. 2017, Cogentix Medical's Interest Expense was $-0.03 Mil. Its Operating Income was $0.14 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2017 )/Interest Expense (Q: Dec. 2017 )
=-1*0.141/-0.029
=4.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Cogentix Medical  (NAS:CGNT) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Cogentix Medical Interest Coverage Related Terms

Thank you for viewing the detailed overview of Cogentix Medical's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Cogentix Medical (Cogentix Medical) Business Description

Traded in Other Exchanges
N/A
Address
5420 Feltl Road, Minnetonka, MN, USA, 55343
Cogentix Medical Inc is a medical device company. The company designs, develops, manufactures and markets a robust line of high-performance fiberoptic and video endoscopy products under the PrimeSight brand that is used across multiple surgical specialties in diagnostic and treatment procedures. Cogentix offers the Urgent PC Neuromodulation System, a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). It also develops Macroplastique an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily resulting from intrinsic sphincter deficiency.
Executives
Nachum Shamir director 12212 TECHNOLOGY BLVD, AUSTIN TX 78727
Brett Reynolds officer: SVP, CFO, Treasurer 5000 W 36TH STREET, MINNEAPOLIS MN 55416
Kenneth A Samet director 800 KING FARM BOULEVARD, 4TH FLOOR, ROCKVILLE MD 20850
Uri Geiger director 221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Accelmed Growth Partners, L.p. 10 percent owner 6 HACHOSHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners Management Ltd. 10 percent owner 6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (gp), L.p. 10 percent owner 6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (agp) Ltd 10 percent owner 6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Cheryl Pegus director 40 RAMLAND ROAD, ORANGEBURG CA 10962
Kenneth H Paulus director 5420 FELTL ROAD, MINNETONKA MN 55343
Sven Wehrwein director
Kevin H Roche director
David W Anderson director 519 LYNMERE ROAD, BRYN MAWR PA 19010

Cogentix Medical (Cogentix Medical) Headlines

From GuruFocus

Cognyte Announces Changes to its Board of Directors

By Business Wire 07-11-2023